Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
M
|
MSCI Inc
SWB:3HM
|
US |
|
B
|
Bayan Resources Tbk PT
XMUN:BNB
|
ID |
|
Banka BioLoo Ltd
NSE:BANKA
|
IN |
|
Balkrishna Industries Ltd
NSE:BALKRISIND
|
IN |
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
3i Group PLC
LSE:III
|
UK |
|
S
|
Sharc International Systems Inc
OTC:INTWF
|
CA |
Reverse DCF
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|